Suzanne Cory

Q: What Schools Are Affiliated With Suzanne Cory

Suzanne Cory is affiliated with the following schools: University of Melbourne, University of Cambridge

Suzanne Cory's AcademicInfluence.com Rankings

Suzanne Cory

Biology

#859

World Rank

#1493

Historical Rank

Molecular Biology

#111

World Rank

#114

Historical Rank

Biochemistry

#561

World Rank

#651

Historical Rank

biology Degrees

Download Badge

Biology

Suzanne Cory's Degrees

Bachelors Biochemistry University of Melbourne

Why Is Suzanne Cory Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams, also a WEHI scientist, whom she met while studying for her PhD at the University of Cambridge, England.

(See a Problem?)

Suzanne Cory's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Bcl-2 protein family: arbiters of cell survival. (1998) (5526)
The Bcl2 family: regulators of the cellular life-or-death switch (2002) (3840)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells (1988) (3273)
The Bcl-2 apoptotic switch in cancer development and therapy (2007) (2047)
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice (1985) (1744)
The Bcl-2 family: roles in cell survival and oncogenesis (2003) (1492)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. (2006) (1223)
Bim: a novel member of the Bcl‐2 family that promotes apoptosis (1998) (1161)
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship (1991) (1132)
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 (1990) (939)
Life-or-death decisions by the Bcl-2 protein family. (2001) (924)
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. (1991) (852)
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (2002) (822)
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. (1995) (774)
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 (1994) (707)
Bcl-2-regulated apoptosis: mechanism and therapeutic potential. (2007) (633)
Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death (1993) (561)
Bim is a suppressor of Myc-induced mouse B cell leukemia. (2004) (510)
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases (2011) (480)
The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice (1986) (449)
Regulation of lymphocyte survival by the bcl-2 gene family. (1995) (416)
Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA (1975) (379)
bcr‐abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. (1990) (373)
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. (1983) (346)
The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry (1997) (345)
bcl-w, a novel member of the bcl-2 family, promotes cell survival. (1996) (330)
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion (1984) (329)
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. (1998) (328)
Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. (1986) (323)
Apoptosomes: engines for caspase activation. (2002) (310)
Transgenic models of tumor development. (1991) (291)
Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. (2001) (277)
Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. (1983) (276)
The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4 (1998) (262)
Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death (1997) (258)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets (2017) (243)
Nucleotide Sequence of N-Formyl-methionyl-transfer RNA (1968) (239)
Killing cancer cells by flipping the Bcl-2/Bax switch. (2005) (206)
ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. (2013) (198)
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. (2004) (197)
Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. (1990) (188)
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. (2012) (180)
bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. (1988) (175)
A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte‐macrophage colony stimulating factor. (1989) (174)
Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. (1999) (173)
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice (1994) (169)
E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. (1993) (168)
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. (1999) (165)
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c‐myc oncogene. (1985) (156)
The Role of Bim, a Proapoptotic BH3‐Only Member of the Bcl‐2 Family, in Cell‐Death Control (2000) (153)
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. (1994) (152)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets. (2018) (150)
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas (2008) (148)
BH3-only proteins in apoptosis at a glance (2012) (145)
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. (1980) (137)
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. (1990) (135)
Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox‐2.4 homeobox gene. (1993) (130)
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. (2010) (129)
A bcr-v-abl oncogene induces lymphomas in transgenic mice (1989) (124)
Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations (1985) (124)
Primary Structure of a Methionine Transfer RNA from Escherichia coli (1968) (121)
Transgenic mice and oncogenesis. (1988) (120)
Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes (1980) (119)
Quality and quantity of accounting students and the stereotypical accountant: Is there a relationship? (1992) (114)
N‐myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross‐regulation with c‐myc. (1989) (113)
Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. (1993) (112)
Tissue expression and subcellular localization of the pro-survival molecule Bcl-w (2001) (105)
Targeting BCL-2-like Proteins to Kill Cancer Cells. (2016) (104)
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1 (2011) (102)
Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes (1988) (102)
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. (2010) (101)
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. (1982) (97)
Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange (1984) (88)
An E mu‐v‐abl transgene elicits plasmacytomas in concert with an activated myc gene. (1990) (80)
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo (2017) (79)
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector (1999) (78)
Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene (1984) (77)
Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. (1980) (77)
Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma (1985) (75)
Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression (1980) (75)
The modified 5'-terminal sequences in messenger RNA of mouse myeloma cells. (1975) (74)
Progenitor tumours from Emu‐bcl‐2‐myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. (1996) (72)
Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions (1992) (72)
A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes (1977) (70)
Untranslated Nucleotide Sequence at the 5′-End of R 17 Bacteriophage RNA (1970) (68)
MYC levels govern hematopoietic tumor type and latency in transgenic mice. (2006) (63)
Oncogene co-operation in leukaemogenesis. (1992) (59)
Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. (1987) (58)
Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members (1999) (57)
Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes. (1981) (56)
Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. (1994) (56)
Interchromosomal recombination of the cellular oncogene c‐myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. (1983) (55)
The nucleotide sequence of methionine transfer RNA-M. (1970) (53)
Matters of life and death: programmed cell death at Cold Spring Harbor. (1998) (51)
Molecular Cloning of Recombinant DNA (1978) (50)
Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias (1987) (50)
The nucleotide sequence of N-formyl-methionyl-transfer RNA. Products of complete digestion with ribonuclease T-1 and pancreatic ribonuclease and derivation of their sequences. (1969) (49)
Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl (1989) (48)
Enforced BCL 2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease ( oncogene / transgenic mice / lymphocyte lifespan / lupus mkce / glomerulonephritis ) (47)
Untranslated Nucleotide Sequences in R17 Bacteriophage RNA (1970) (46)
Developmental regulation of the bcl-2 family during spermatogenesis: Insights into the sterility of bcl-w−/− male mice (2001) (44)
Transgenic models for haemopoietic malignancies. (1991) (43)
T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC (2005) (42)
Cloned pairs of variable region genes for immunoglobulin heavy chains isolated from a clone library of the entire mouse genome. (1979) (41)
Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. (1999) (41)
In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-1B lineage populations. (1990) (41)
Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain. (1980) (41)
Organization of genes and spacers within the mouse immunoglobulin VH locus. (1981) (39)
Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations. (1989) (39)
Whistleblowing and management accounting: An approach (1989) (38)
Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl. (1989) (37)
Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. (1994) (37)
Organization and Expression of Murine Immunoglobulin Genes (1981) (36)
Subversion of the Bcl-2 life/death switch in cancer development and therapy. (2005) (35)
Fusion of DNA region to murine immunoglobulin heavy chain locus corresponds to plasmacytoma‐associated chromosome translocation. (1983) (35)
Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy. (1988) (34)
Enhanced cell survival and tumorigenesis. (1994) (32)
B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. (1994) (32)
bcr-abl-Induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro. (1992) (32)
Murine c-myc retroviruses alter the growth requirements of myeloid cell lines. (1987) (30)
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice (2018) (30)
Sequence of 51 nucleotides at the 3'-end of R17 bacteriophage RNA. (1972) (29)
Nucleotide sequence from the 5' end to the first cistron of R17 bacteriophage ribonucleic acid. (1972) (28)
Cell death throes. (1998) (28)
Molecular cloning of seven mouse immunoglobulin kappa chain messenger ribonucleic acids. (1980) (27)
Studies on the Escherichia coli Methionine transfer ribonucleic acids. (1969) (26)
Fascinating death factor (1994) (25)
Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research. (1996) (24)
Modified nucleosides and 5'-end groups in purified mouse immunoglobulin light chain mRNA and rabbit globin mRNA detected by borohydride labelling. (1976) (22)
Nucleotide sequences of fragments of R17 bacteriophage RNA from the region immediately preceding the coat-protein cistron. (1972) (20)
Murine erythroid cell lines derived with c-myc retroviruses respond to leukemia-inhibitory factor, erythropoietin, and interleukin 3. (1991) (18)
Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis. (2020) (16)
Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains. (1980) (16)
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells (2018) (16)
Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice (2014) (15)
FoxO3 suppresses Myc-driven lymphomagenesis (2016) (15)
The role of bcl-2 in lymphoid differentiation and neoplastic transformation. (1992) (14)
Separation of two initiator transfer RNAs from E. coli (1968) (14)
Recombination events near the immunoglobulin Cmu gene join variable and constant region genes, switch heavy-chain expression, or inactivate the locus. (1981) (14)
A Factor Analysis of the Skills Necessary in Accounting Graduates (2012) (14)
c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia. (1986) (14)
Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained. (2014) (14)
Mnt modulates Myc-driven lymphomagenesis (2017) (13)
Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl. (1997) (12)
The Bcl-2-regulated apoptosis switch: mechanism and therapeutic potential (2009) (12)
The incorporation of [32P]phosphate into nucleic acids of normal and boron-deficient bean roots (1966) (12)
Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis. (1999) (12)
THE LOCATIONAL DETERMINANTS OF U . S . FOREIGN DIRECT INVESTMENT IN THE EUROPEAN UNION (1997) (12)
Amino acid-dependent ATP-pyrophosphate exchange in normal and boron deficient bean roots (1966) (11)
Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection (2012) (11)
corrigenda: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (2002) (11)
Identical 3′ non-coding sequences in five mouse Ig κ chain mRNAs favour a unique Cκ gene (1979) (11)
Cloned embryonic DNA sequences flanking the mouse immunoglobulin C gamma 3 and C gamma 1 genes. (1980) (10)
Further studies on the incorporation of [32P] phosphate into nucleic acids of normal and boron-deficient tissue (1967) (9)
Activation of the c-myc oncogene in B and T lymphoid tumors. (1984) (9)
The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. (1987) (9)
Immunology: Wavering on commitment (1999) (9)
MODIFIED NUCLEOSIDES AND BIZARRE 5'-TERMINI IN MOUSE MYELOMA MESSENGER-RNA (1975) (8)
Noncoding nucleotide sequence in the 3'-terminal region of a mouse immunoglobulin kappa chain messenger RNA determined by analysis of complementary DNA. (1977) (8)
Translation of immunoglobulin mRNAs in a wheat germ cell-free system (1974) (7)
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice (2016) (7)
Student Perceptions of the Insurance Profession (2007) (7)
Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis (2018) (6)
Classroom Implementation of the National Science Education Standards: A Snapshot Instrument To Provide Feedback and Reflection for Teachers. (1999) (6)
2 + 2 = ? It's time for Americans to become more financially literate, and Accountants can help them do so (2008) (5)
Generation ofAltered Transcripts byRetroviral Insertion within the c-mybGeneinTwoMurineMonocytic Leukemias (1987) (5)
Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice (2016) (5)
Oncogenes and B-lymphocyte neoplasia. (1983) (5)
Lessons from Translocations and Transgenic Mice: Constitutive c-myc Expression Predisposes to Neoplasia (1986) (5)
Hispanic College Students’ Perceptions of Members of Business Occupations: An Exploratory Study (2009) (4)
Synthesis of complementary RNA on RNA templates using the DNA-dependent RNA polymerase of Escherichia coli. (1977) (4)
Immunoglobulin JH rearrangement in a T-cell line reflects fusion to the DH locus at a sequence lacking the nonamer recognition signal (2004) (4)
Expression of the immunoglobulin C , gene in mouse T and B lymphoid and myeloid cell lines ( p and K mRNA species / hibridization / recombinant DNA / rearranged genes ) (4)
WOMEN AND THE ENGINEERING PROFESSION: THE STEREOTYPICAL ENGINEER (2008) (4)
Moral Disengagement in Science and Business Students: An Exploratory Study (2015) (4)
A Joint Odyssey into Cancer Genetics (2019) (4)
Moral Disengagement in Business and Humanities Majors: An Exploratory Study. (2014) (4)
Apoptosis. Fascinating death factor. (1994) (4)
Phosphatidylserine hide-and-seek (2018) (4)
Deregulation of cell survival in lymphomagenesis. (1997) (4)
Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice. (1989) (2)
Constituents in Conflict: Serving External Stakeholders (2013) (2)
Comparison of immunoglobulin chains made in ascites extract and reticulocyte lysate programmed with mRNA from four mouse myelomas. (1977) (2)
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation (2021) (2)
Masterminding B Cells (2015) (2)
Immunoglobulin variable region genes. (1984) (2)
Institutions: Australian academy is fair to women (2013) (2)
Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1. (1989) (2)
A rapid procedure for screening fibroblast packaging cell lines for secretion of selectable retrovirus. (1993) (2)
Analysis of the leukemogenic properties of the bcr-v-abl and GM-CSF genes using a new retroviral vector. (1989) (2)
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells (2018) (1)
Number and organisation of immunoglobulin variable region genes in the mouse. (1981) (1)
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice (2018) (1)
Sound Financial Decision Making for Entrepreneurs: Can the Gaap Cash Flow Statement Mislead? (2011) (1)
The Trojan Horses: Japanese and U.S. Presence in Europe (1994) (1)
Decreased cell death and increased self‐renewal: two facets of hematopoietic cell transformation (1992) (1)
Donald Metcalf: The father of modern hematology (2015) (1)
Moral Disengagement and Locus of Control in Business School Freshmen: Gender Differences (2015) (1)
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice (2016) (1)
James (Jim) Douglas Morrison: Leader in mass spectroscopy (2013) (1)
The BH3 Mimetic, ABT-737, Is Effective Against Bcl-2 Overexpressing Lymphoid Tumors. (2006) (1)
Myc and Mnt in lymphomagenesis (2008) (0)
The Role of bcl — 2 in Lymphoid Differentation and Transformation (1993) (0)
Immortalization of Primitive Hematopoietic-Cells Using Retroviral Gene Delivery (1993) (0)
by the infection conditions. mice by a bcr-abl retrovirus is influenced Hematologic disease induced in BALB/c (2013) (0)
Materials and Methods (1965) (0)
Transgenic Window on Haematopoietic Neoplasia (1990) (0)
Hox 2.4 and a Milieu of High Il-3 Concentration Deliver Synergistic Self-Renewal Signals (1993) (0)
The many roles of apoptotic cell death in the immune system (LL3-6) Chairperson: Shin Yonehara (2010) (0)
The cell survival Bcl-w protein is required for spermatogenesis (1998) (0)
Role of BH3-only protein Bim in autoimmune and degenerative diseases (2003) (0)
Oncogene impact on haemopoietic cells (1989) (0)
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bc1-2 transgene (0)
Constitutive c myc expression and lymphoid neoplasia (1987) (0)
The Bcl-2 Family: Arbiters of Life and Death (2000) (0)
TRANSGENIC MODELS OF LEUKEMOGENESIS (1993) (0)
Author Note: A Joint Odyssey into Cancer Genetics (2019) (0)
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis (2023) (0)
Abstract IA31: Harnessing death for life. (2015) (0)
Identical 3' non-coding sequences in five mouse Ig kappa chain mRNAs favour a unique C kappa gene. (1979) (0)
The transcriptional represser Mnt is a functional antagonist of the proto-oncoprotein Myc (2017) (0)
Erratum: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (Nature (2002) 415 (922-926)) (2002) (0)
Transgenic Mice as Models for the Development of Haemopoietic Neoplasia (1989) (0)
Frontmatter (1983) (0)
Nucleic Acids Research (2013) (0)
How, when, and why do lymphocytes die? (2000) (0)
Discovery of BCL-2 as an Oncogene and the First Inhibitor of Apoptosis (2016) (0)
The Bcl-2 family: Making life and death decisions in cells (2005) (0)
Professor David James Kemp OAM FAA1945–2013 (2014) (0)
Galileo in the gallery (2006) (0)
An investigation of audit practice quality (1988) (0)
Joan Heath interviews Suzanne Cory and Joan Steitz: a female perspective of science in the swinging ‘60s (2022) (0)
A FACTOR ANALYSIS OF OCCUPATIONAL STEREOTYPES FOR HIGH SCHOOL STUDENTS AND ADULTS (2013) (0)
An Exploratory Study: Moral Disengagement Levels in Accounting Majors (2017) (0)
Texas Lone Star Connections 1 (2009) (0)
The marketing major and Hispanic students: An occupational stereotype? (2014) (0)
49 Regulation of Apoptosis by the Bcl-2 Family (2012) (0)
BCL-2: From Translocation to Therapy (2008) (0)

This paper list is powered by the following services:

Other Resources About Suzanne Cory

What Schools Are Affiliated With Suzanne Cory?

Suzanne Cory is affiliated with the following schools:

Suzanne Cory's Academic­Influence.com Rankings

Suzanne Cory's Degrees

Why Is Suzanne Cory Influential?

Suzanne Cory's Published Works

Published Works

Other Resources About Suzanne Cory

What Schools Are Affiliated With Suzanne Cory?

Suzanne Cory's AcademicInfluence.com Rankings